Tempest in a teapot: A systematic review of HPV vaccination and risk compensation research
Reads0
Chats0
TLDR
None of the studies of sexual behaviors and/or biological outcomes found evidence of riskier behaviors or higher rates of STIs after HPV vaccination, which should be reassuring to parents and health care providers.Abstract:
There has been some concern among parents and in the media that vaccinating children against human papillomavirus could be seen as giving children permission to engage in risky sexual behaviors (also known as sexual disinhibition). Several studies have found this concern to be unfounded but there have been no attempts to synthesize the relevant studies in order to assess if there is evidence of sexual disinhibition. The aim of this study was to synthesize recent literature examining sexual behaviors and biological outcomes (e.g., sexually transmitted infections) post-HPV vaccination. We reviewed literature from January 1, 2008-June 30, 2015 using PubMed, CINAHL, and Embase with the following search terms: [(sex behavior OR sex behavior OR sexual) AND (human papillomavirus OR HPV) AND (vaccines OR vaccine OR vaccination)] followed by a cited reference search. We included studies that examined biological outcomes and reported behaviors post-vaccination in both males and females. Studies were reviewed by title and abstract and relevant studies were examined as full-text articles. We identified 2,503 articles and 20 were eventually included in the review. None of the studies of sexual behaviors and/or biological outcomes found evidence of riskier behaviors or higher rates of STIs after HPV vaccination. Instead, the studies found that vaccinated compared to unvaccinated individuals were less likely to report vaginal intercourse without a condom (OR = 0.5; 95%CI = 0.4-0.6) and non-use of contraception (OR = 0.27; 95%CI = 0.15-0.48) and unvaccinated participants had higher rates of Chlamydia (OR = 2.3; 95%CI = 1.06-5.00). These results should be reassuring to parents and health care providers.read more
Citations
More filters
Journal ArticleDOI
Real‐world effectiveness of HPV vaccination against cervical neoplasia among birth cohorts ineligible for routine vaccination
TL;DR: In this article , the authors presented the first real-world effectiveness study of HPV vaccination on high grade cervical lesions from Norway, among women who received HPV vaccine outside the routine program, and they performed an observational study of all Norwegian women born 1975 to 1996 and retrieved individual data from nationwide registries on HPV vaccination status and incidence of histologically verified high-grade cervical neoplasia during 2006 to 2016.
Journal ArticleDOI
Human papillomavirus vaccination at the first opportunity: An overview
Robert A. Bednarczyk,Noel T. Brewer,Melissa B. Gilkey,Sherri Zorn,Rebecca B. Perkins,Kristin Oliver,Debbie Saslow +6 more
TL;DR: For example, the authors summarizes the current recommendations and available evidence regarding HPV vaccination starting at 9-year-old, including recent studies and trials documenting the effectiveness of HPV vaccination at 9 in supporting vaccine series completion.
Journal ArticleDOI
Vaccine Hesitancy in Women's Health.
TL;DR: A review of vaccine hesitancy in women's health is presented in this article , where the authors explore common themes in patients' apprehension to receive vaccines and provide strategies for providers to implement which may reduce vaccine-hesitancy among patients.
Journal ArticleDOI
Helmets improve estimations of depth and visual angle to safe targets.
TL;DR: These findings help define the interaction between safety devices and target type, thereby contributing to the debate between advocates of prevention models and those who maintain that these are offset by compensatory strategies.
Journal ArticleDOI
Increasing Ebola transmission behaviors 6 months post-vaccination: Comparing vaccinated and unvaccinated populations near 2018 Mbandaka Ebola outbreak in the Democratic Republic of Congo.
Nicole A. Hoff,Anna Bratcher,Patrick Mukadi,Steve Ahuka,Michel Kabamba,Kamy Musene,Megan Halbrook,Camille Dzogong,Guillaume Ngoie Mwamba,Placide Mbala,J. Daniel Kelly,Jean Paul Kompany,Merly Tambu,Didine Kaba,Benoit Kebela-Ilunga,Jean Jacque Muyemebe-Tamfum,Anne W. Rimoin +16 more
TL;DR: In this paper, the authors found an overall increase in the proportion of both unvaccinated and vaccinated individuals in Mbandaka who participated in risky activities post-outbreak, despite significant efforts to inform the population of risky behaviors.
References
More filters
Journal ArticleDOI
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
TL;DR: Moher et al. as mentioned in this paper introduce PRISMA, an update of the QUOROM guidelines for reporting systematic reviews and meta-analyses, which is used in this paper.
Journal Article
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
TL;DR: The QUOROM Statement (QUality Of Reporting Of Meta-analyses) as mentioned in this paper was developed to address the suboptimal reporting of systematic reviews and meta-analysis of randomized controlled trials.
Book
Cochrane Handbook for Systematic Reviews of Interventions
Julian P T Higgins,Sally Green +1 more
TL;DR: The Cochrane Handbook for Systematic Reviews of Interventions is the official document that describes in detail the process of preparing and maintaining Cochrane systematic reviews on the effects of healthcare interventions.
Tobacco smoke and involuntary smoking
Michael C. R. Alavanja,John A. Baron,Ross C. Brownson,Patricia A. Buffler,David M. DeMarini,Mirjana V. Djordjevic,Richard Doll,Elizabeth T. H. Fontham,Yu-Tang Gao,Nigel Gray,Prakash C. Gupta,A. K. Hackshaw,Stephen S. Hecht,Kirsti Husgafvel-Pursiainen,Elena Matos,Richard Peto,David H. Phillips,Jonathan M. Samet,Gary D. Stoner,Michael J. Thun,Jean Trédaniel,Paolo Vineis,H.-Erich Wichmann,Anna H. Wu,David Zaridze +24 more
Journal Article
Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
Lauri E. Markowitz,Eileen F. Dunne,Mona Saraiya,Herschel W. Lawson,Harrell W. Chesson,Elizabeth R. Unger +5 more
TL;DR: The first statement by the Advisory Committee on Immunization Practices (ACIP) on the use of a quadrivalent human papillomavirus (HPV) vaccine was made by the U.S. Food and Drug Administration on June 8, 2006 as mentioned in this paper.